Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Meier

Showing results (621-630 of 831) with videos related to

Pageof 84
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 11, 2000
Characterization of inducible nature of MRP3 in rat liverK Ogawa, H Suzuki, T Hirohashi, et al.
Diabetes, Obesity & Metabolism|January 26, 2023
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmesVanita R Aroda, Umut Erhan, Peter Jelnes, et al.
Regulatory Peptides|April 11, 2003
The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP)Juris J Meier, Baptist Gallwitz, Nina Siepmann, et al.
The Permanente Journal|July 26, 2016
Voices of the "99 Percent": The Role of Online Narrative to Improve Health CareBeth Sundstrom, Stephanie J Meier, Michael Anderson, et al.
Pharmaceutical Research|August 5, 2004
P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptideKeith A Hoffmaster, Ryan Z Turncliff, Edward L LeCluyse, et al.
Diabetes|November 25, 2004
Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjectsJuris J Meier, Baptist Gallwitz, Bartholomaeus Kask, et al.
Diabetes, Obesity & Metabolism|July 6, 2018
Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetesJulio Rosenstock, Yehuda Handelsman, Josep Vidal, et al.
Diabetes Care|August 6, 2011
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trialMichael A Nauck, Stefano Del Prato, Juris J Meier, et al.
Journal of Hepatology|February 2, 1999
Decreased Na+-dependent taurocholate uptake and low expression of the sinusoidal Na+-taurocholate cotransporting protein (Ntcp) in livers of mdr2 P-glycoprotein-deficient miceN R Koopen, H Wolters, P Voshol, et al.
Communications Biology|August 16, 2020
Chemically induced mutations in a MutaMouse reporter gene inform mechanisms underlying human cancer mutational signaturesMarc A Beal, Matthew J Meier, Danielle P LeBlanc, et al.
Pageof 84

Showing results (621-630 of 831) with videos related to

Sort By:
Pageof 84
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 11, 2000
Characterization of inducible nature of MRP3 in rat liverK Ogawa, H Suzuki, T Hirohashi, et al.
Diabetes, Obesity & Metabolism|January 26, 2023
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmesVanita R Aroda, Umut Erhan, Peter Jelnes, et al.
Regulatory Peptides|April 11, 2003
The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP)Juris J Meier, Baptist Gallwitz, Nina Siepmann, et al.
The Permanente Journal|July 26, 2016
Voices of the "99 Percent": The Role of Online Narrative to Improve Health CareBeth Sundstrom, Stephanie J Meier, Michael Anderson, et al.
Pharmaceutical Research|August 5, 2004
P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptideKeith A Hoffmaster, Ryan Z Turncliff, Edward L LeCluyse, et al.
Diabetes|November 25, 2004
Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjectsJuris J Meier, Baptist Gallwitz, Bartholomaeus Kask, et al.
Diabetes, Obesity & Metabolism|July 6, 2018
Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetesJulio Rosenstock, Yehuda Handelsman, Josep Vidal, et al.
Diabetes Care|August 6, 2011
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trialMichael A Nauck, Stefano Del Prato, Juris J Meier, et al.
Journal of Hepatology|February 2, 1999
Decreased Na+-dependent taurocholate uptake and low expression of the sinusoidal Na+-taurocholate cotransporting protein (Ntcp) in livers of mdr2 P-glycoprotein-deficient miceN R Koopen, H Wolters, P Voshol, et al.
Communications Biology|August 16, 2020
Chemically induced mutations in a MutaMouse reporter gene inform mechanisms underlying human cancer mutational signaturesMarc A Beal, Matthew J Meier, Danielle P LeBlanc, et al.
Pageof 84